LEXARIA BIOSCIENCE CORP. Operating Lease, Weighted Average Discount Rate, Percent
LEXARIA BIOSCIENCE CORP. (LEXX) had Operating Lease, Weighted Average Discount Rate, Percent of 7.25% as of 2023-05-31, per its 10-Q filed 2023-07-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2023-07-14
- 2023-05-31: Operating Lease, Weighted Average Discount Rate, Percent 7.25%.
- 2023-02-28: Operating Lease, Weighted Average Discount Rate, Percent 7.25%.
- 2022-11-30: Operating Lease, Weighted Average Discount Rate, Percent 7.25%.
- 2022-08-31: Operating Lease, Weighted Average Discount Rate, Percent 7.25%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2023-05-31 | 7.25% 10-Q · filed 2023-07-14 |
| 2023-02-28 | 7.25% 10-Q · filed 2023-04-14 |
| 2022-11-30 | 7.25% 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | 7.25% 10-Q · filed 2023-07-14 |
| 2022-05-31 | 7.50% 10-Q · filed 2022-07-14 |
| 2022-02-28 | 7.50% 10-Q · filed 2022-04-11 |
| 2021-11-30 | 7.50% 10-Q · filed 2022-01-14 |
| 2021-08-31 | 7.25% 10-K · filed 2022-11-28 |
| 2021-05-31 | 7.25% 10-Q · filed 2021-07-15 |
| 2020-11-30 | 7.25% 10-Q · filed 2021-01-14 |
| 2020-08-31 | 7.25% 10-K · filed 2021-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |